Non-contact Endoscopy at Covid-19 Outbreak
- Conditions
- Infectious DiseaseGastrointestinal Disease
- Interventions
- Device: Non-contact MCE system
- Registration Number
- NCT04320953
- Lead Sponsor
- Changhai Hospital
- Brief Summary
The COVID-19 outbreak and spread throughout the world now constitutes a global public health emergency. Direct contact between doctors and patients in daily practice bears potential risk of Covid-19 infection, and telemedicine, or non-contact medicine, in this circumstance, offers an ideal solution. Remote controlling capsule endoscopy system for gastric examination was recently developed and applicated in clinical practice.
- Detailed Description
The novel non-contact magnetically-controlled capsule endoscopy (MCE) system (Ankon Technologies, China) adds a remote control workstation and a audio-visual exchange system to the original well-establish MCE system, which consists of a robotic magnetic arm, a workstation (now bypassed) and a capsule endoscope, and boasts a 90% sensitivity and 94% specificity for diagnosing gastric focal lesions. This feasibility study aims to evaluate the technical success, clinical success and adverse events of the first clinical application of non-contact MCE system.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
- Signed the informed consents before joining this study
- Dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy
- Refused abdominal surgery to take out the capsule in case of capsule retention
- Implanted pacemaker, except the pacemaker is compatible with MRI
- Other implanted electromedical devices or magnetic metal foreign bodies
- Pregnancy or suspected pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Non-contact MCE examination Non-contact MCE system Study subject in this arm receives non-contact MCE examination.
- Primary Outcome Measures
Name Time Method Technical success During the procedure Maneuvarability of the remote control MCE system
- Secondary Outcome Measures
Name Time Method Adverse events During and within 2 weeks after the procedure Adverse events during and after the procedure
Clinical success During the procedure Complete observation of the mucosa (\>90% of the mucosa observed) in gastric cardia, fundus, body, angulus, antrum and pylorus
Trial Locations
- Locations (1)
Changhai Hospital
🇨🇳Shanghai, China